BioSig Technologies, Inc. announces a public offering of common stock or pre-funded warrants.
The offering is underwritten and remains subject to market conditions.
Proceeds will be used for purchasing gold bullion, working capital, and general corporate purposes.
Public Offering Announcement
BioSig Technologies, Inc. intends to offer common stock through an underwritten public offering.
Use of Proceeds
The net proceeds from the offering will be used for purchasing gold bullion, working capital, and general corporate purposes.
Underwriters
Clear Street and Needham & Company are acting as joint book-running managers for the offering.
- The completion of the offering is subject to market conditions and timing uncertainties.
- Investors should carefully review the preliminary prospectus supplement and accompanying base prospectus before investing.
BioSig Technologies Inc. is making strategic moves to secure funding and enhance its financial position through the public offering.